Header Logo

Connection

DANIEL HAMSTRA to Quality of Life

Back to Details
This is a "connection" page, showing publications DANIEL HAMSTRA has written about Quality of Life.
DANIEL HAMSTRA
Connection Strength
2.191
Quality of Life
  1. Patient-Reported Quality of Life During Prostate Cancer Radiation Therapy: Insights Into the Patient Experience. Int J Radiat Oncol Biol Phys. 2021 07 15; 110(4):1129-1131.
    View in: PubMed
    Score: 0.374
  2. Point: Which Treatment Modality for Localized Prostate Cancer Yields Superior Quality of Life: Radiotherapy or Prostatectomy? Quality of Life is Better After Modern Radiotherapy Compared With Surgery. Oncology (Williston Park). 2017 11 15; 31(11):830-2, 835.
    View in: PubMed
    Score: 0.290
  3. Sexual quality of life following prostate intensity modulated radiation therapy (IMRT) with a rectal/prostate spacer: Secondary analysis of a phase 3 trial. Pract Radiat Oncol. 2018 Jan - Feb; 8(1):e7-e15.
    View in: PubMed
    Score: 0.283
  4. Multi-institutional prospective evaluation of bowel quality of life after prostate external beam radiation therapy identifies patient and treatment factors associated with patient-reported outcomes: the PROSTQA experience. Int J Radiat Oncol Biol Phys. 2013 Jul 01; 86(3):546-53.
    View in: PubMed
    Score: 0.210
  5. Postprostatectomy Radiotherapy Timing and Long-Term Health-Related Quality of Life. JAMA Netw Open. 2024 Oct 01; 7(10):e2440747.
    View in: PubMed
    Score: 0.117
  6. Long-term follow-up after radiotherapy for prostate cancer with and without rectal hydrogel spacer: a pooled prospective evaluation of bowel-associated quality of life. BJU Int. 2020 09; 126(3):367-372.
    View in: PubMed
    Score: 0.087
  7. Quality of life is not compromised with intensification of androgen therapy in recurrent prostate cancer. Lancet Oncol. 2018 10; 19(10):1275-1276.
    View in: PubMed
    Score: 0.077
  8. Patient-Reported Sexual Aid Utilization and Efficacy After Radiation Therapy for Localized Prostate Cancer. Int J Radiat Oncol Biol Phys. 2018 06 01; 101(2):376-386.
    View in: PubMed
    Score: 0.074
  9. A multi-institutional phase 2 trial of prostate stereotactic body radiation therapy (SBRT) using continuous real-time evaluation of prostate motion with patient-reported quality of life. Pract Radiat Oncol. 2018 Jan - Feb; 8(1):40-47.
    View in: PubMed
    Score: 0.071
  10. External Beam Radiation Therapy or Brachytherapy With or Without Short-course Neoadjuvant Androgen Deprivation Therapy: Results of a Multicenter, Prospective Study of Quality of Life. Int J Radiat Oncol Biol Phys. 2017 06 01; 98(2):304-317.
    View in: PubMed
    Score: 0.069
  11. Continued Benefit to Rectal Separation for Prostate Radiation Therapy: Final Results of?a?Phase III Trial. Int J Radiat Oncol Biol Phys. 2017 04 01; 97(5):976-985.
    View in: PubMed
    Score: 0.068
  12. Predictors of multidomain decline in health-related quality of life after stereotactic body radiation therapy (SBRT) for prostate cancer. Cancer. 2017 05 01; 123(9):1635-1642.
    View in: PubMed
    Score: 0.068
  13. Multinational Prospective Study of Patient-Reported Outcomes After Prostate Radiation Therapy: Detailed Assessment of Rectal Bleeding. Int J Radiat Oncol Biol Phys. 2016 11 15; 96(4):770-777.
    View in: PubMed
    Score: 0.066
  14. Patient-reported quality of life after stereotactic body radiotherapy (SBRT), intensity modulated radiotherapy (IMRT), and brachytherapy. Radiother Oncol. 2015 Aug; 116(2):179-84.
    View in: PubMed
    Score: 0.062
  15. Dose to the inferior rectum is strongly associated with patient reported bowel quality of life after radiation therapy for prostate cancer. Radiother Oncol. 2014 Feb; 110(2):291-7.
    View in: PubMed
    Score: 0.056
  16. Comparative effectiveness study of patient-reported outcomes after proton therapy or intensity-modulated radiotherapy for prostate cancer. Cancer. 2014 Apr 01; 120(7):1076-82.
    View in: PubMed
    Score: 0.055
  17. Randomized phase II trial of urethral sparing intensity modulated radiation therapy in low-risk prostate cancer: implications for focal therapy. Radiat Oncol. 2012 Jun 09; 7:82.
    View in: PubMed
    Score: 0.050
  18. Absorbable Hydrogel Spacer Use in Prostate Radiotherapy: A Comprehensive Review of Phase 3 Clinical Trial Published Data. Urology. 2018 May; 115:39-44.
    View in: PubMed
    Score: 0.018
  19. Relief of Urinary Symptom Burden after Primary Prostate Cancer Treatment. J Urol. 2017 02; 197(2):376-384.
    View in: PubMed
    Score: 0.017
  20. Hydrogel Spacer Prospective Multicenter Randomized Controlled Pivotal Trial: Dosimetric?and Clinical Effects of Perirectal Spacer Application in Men Undergoing Prostate?Image Guided Intensity Modulated Radiation?Therapy. Int J Radiat Oncol Biol Phys. 2015 Aug 01; 92(5):971-977.
    View in: PubMed
    Score: 0.015
  21. Defining a standard set of patient-centered outcomes for men with localized prostate cancer. Eur Urol. 2015 Mar; 67(3):460-7.
    View in: PubMed
    Score: 0.015
  22. Neoadjuvant androgen deprivation therapy leads to immediate impairment of vitality/hormonal and sexual quality of life: results of a multicenter prospective study. Urology. 2013 Dec; 82(6):1363-8.
    View in: PubMed
    Score: 0.014
  23. Patient-reported outcomes after 3-dimensional conformal, intensity-modulated, or proton beam radiotherapy for localized prostate cancer. Cancer. 2013 May 01; 119(9):1729-35.
    View in: PubMed
    Score: 0.013
  24. Prediction of erectile function following treatment for prostate cancer. JAMA. 2011 Sep 21; 306(11):1205-14.
    View in: PubMed
    Score: 0.012
  25. Salvage external beam radiotherapy for prostate cancer after radical prostatectomy: current status and controversy. Oncology (Williston Park). 2010 Jul; 24(8):692-700, 702.
    View in: PubMed
    Score: 0.011
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.